SERA · ISSUER CIK 1534969
SERA PROGNOSTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 5 SERA PROGNOSTICS, INC. insiders reported $0.00 of open-market purchases and $80K of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 6 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$80KInsider selling
−$80KNet open-market
Oct 13, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202617:06 | Oct 12, 2026 | SERA | Chief Medical Officer | S · Sell | $2.03 | −8,024 | 83,565 | -9% | −$16K | ||
| Sep 11, 202616:07 | Sep 10, 2026 | SERA | Chief Commercial Officer | S · Sell | $2.00 | −1,800 | 76,198 | -2% | −$4K | ||
| Sep 11, 202616:07 | Sep 10, 2026 | SERA | Chief Executive Officer, Director | S · Sell | $2.00 | −7,022 | 837,848 | -1% | −$14K | ||
| Sep 11, 202616:07 | Sep 10, 2026 | SERA | Chief Medical Officer | S · Sell | $2.00 | −486 | 91,589 | -1% | −$972.00 | ||
| Sep 11, 202616:07 | Sep 10, 2026 | SERA | General Counsel | S · Sell | $2.00 | −2,190 | 159,566 | -1% | −$4K | ||
| Sep 9, 202616:07 | Sep 8, 2026 | SERA | Chief Executive Officer, Director | S · Sell | $2.00 | −20,139 | 844,870 | -2% | −$40K | ||
| Sep 1, 202617:50 | Aug 31, 2026 | SERA | Chief Financial Officer | A · Grant | — | +117,924 | 117,924 | New | — |